RenovoRx, Inc. (RNXT) Tops Q2 EPS by 1c

RenovoRx, Inc. (NASDAQ: RNXT) reported Q2 EPS of ($0.08), $0.01 better than the analyst estimate of ($0.09). Revenue for the quarter came in at $40 thousand versus the consensus estimate of $287.97 thousand.

For earnings history and earnings-related data on RenovoRx, Inc. (RNXT) click here.

You May Also Be Interested In

• Lyntris opens at $15.50, below IPO price of $17.50
• Scotts Miracle-Gro (SMG) call put ratio 15 calls to 1 put with a focus on August 62.50 calls as share price up 3.4%
• Lowe's slashes full-year sales outlook amid DIY spending pressure